Clinical Trial Update: Tranexamic Acid in Nasal Mohs Reconstruction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating tranexamic acid to reduce postoperative bleeding in nasal Mohs reconstruction for facial skin cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin Cancer

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Postoperative Bleeding, Skin Cancer Face | Phase 2 | Status: RECRUITING